menu
    • menu

    Company profile for EpimAb Biotherapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    EpimAb Biotherapeutics is a privately owned biopharmaceutical R&D company based in Shanghai with a proprietary, unique and efficient technology called FIT-Ig® (Fabs-In-Tandem Immunoglobulin) that generates bispecific molecules with antibody-like properties. With this innovative platform, EpimAb is creating a potentially game-changing pipeline of its own novel bispecific antibody therapeutics focused around immuno-oncology and...
    EpimAb Biotherapeutics is a privately owned biopharmaceutical R&D company based in Shanghai with a proprietary, unique and efficient technology called FIT-Ig® (Fabs-In-Tandem Immunoglobulin) that generates bispecific molecules with antibody-like properties. With this innovative platform, EpimAb is creating a potentially game-changing pipeline of its own novel bispecific antibody therapeutics focused around immuno-oncology and other areas of high value to patients. EpimAb is further committed to diversifying its portfolio of FIT-Igs together with partners in order to further validate the flexibility and robustness of the format.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EpimAb BiotherapeuticsChina Flag
    Country
    Country
    China
    Address
    Address
    6th Floor, Building 2, Jinchuang Building, 702 Zhongke Road Zhangjiang High-T...
    Telephone
    Telephone
    +86-21-61951000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.epimab.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/epimab-biotherapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Juri, EpimAb Ink Global Deal on KLK2 Prostate Therapy
    Juri, EpimAb Ink Global Deal on KLK2 Prostate Therapy

    27 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/27/3088426/0/en/Juri-Biosciences-a-TCG-Labs-Soleil-Portfolio-Company-and-EpimAb-Biotherapeutics-Enter-into-a-Worldwide-Licensing-Agreement-for-KLK2-Directed-T-Cell-Engager-in-Metastatic-Prostate-C.html

    GLOBENEWSWIRE
    27 May 2025
    Share Share
    Medigene, EpimAb Partner On TCR-Guided T Cell Engagers Development
    Medigene, EpimAb Partner On TCR-Guided T Cell Engagers Development

    27 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/27/3033551/0/en/Medigene-and-EpimAb-Biotherapeutics-Enter-into-a-Co-Development-Partnership-for-TCR-Guided-T-Cell-Engagers.html

    GLOBENEWSWIRE
    27 Feb 2025
    Share Share
    Candid Therapeutics & EpimAb Collaborate on T-Cell Engagers
    Candid Therapeutics & EpimAb Collaborate on T-Cell Engagers

    16 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241216821817/en

    BUSINESSWIRE
    16 Dec 2024
    Share Share
    EpimAb to Present Late-breaking Abstract on Preclinical Results of EMB-07
    EpimAb to Present Late-breaking Abstract on Preclinical Results of EMB-07

    05 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240305434743/en/EpimAb-Biotherapeutics-to-Present-Late-breaking-Abstract-on-Preclinical-Results-of-EMB-07-at-the-2024-American-Association-for-Cancer-Research-Annual-Meeting

    BUSINESSWIRE
    05 Mar 2024
    Share Share
    EpimAb to Present a Late-Breaking Abstract of First-in-Human Data of EMB-06
    EpimAb to Present a Late-Breaking Abstract of First-in-Human Data of EMB-06

    31 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231031183230/en

    BUSINESSWIRE
    31 Oct 2023
    Share Share
    EpimAb Biotherapeutics & Almirall Announce Bispecific Antibody License Agreement
    EpimAb Biotherapeutics & Almirall Announce Bispecific Antibody License Agreement

    12 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231011383566/en

    BUSINESSWIRE
    12 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search